TABLE 3.
Age group (yr) | No. of subjects examined (% seroconverted) |
|
---|---|---|
Inaba | Ogawa | |
<18 | 33 (70) | 32 (34) |
18-30 | 417 (55) | 414 (36) |
31-40 | 250 (44) | 249 (28) |
>40 | 277 (33) | 271 (22) |
Total | 977 (46) | 966 (30) |
Age group (yr) | No. of subjects examined (% seroconverted) |
|
---|---|---|
Inaba | Ogawa | |
<18 | 33 (70) | 32 (34) |
18-30 | 417 (55) | 414 (36) |
31-40 | 250 (44) | 249 (28) |
>40 | 277 (33) | 271 (22) |
Total | 977 (46) | 966 (30) |